SPIN2A
gene geneOn this page
Also known as DXF34TDRD25
Summary
SPIN2A (spindlin family member 2A, HGNC:20694) is a protein-coding gene on chromosome Xp11.21, encoding Spindlin-2A (Q99865). May be involved in the regulation of cell cycle progression.
This gene encodes one of three members of the DXF34 gene family, located in a 100-kb region of chromosome Xp11.21.
Source: NCBI Gene 54466 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_019003
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20694 |
| Approved symbol | SPIN2A |
| Name | spindlin family member 2A |
| Location | Xp11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DXF34, TDRD25 |
| Ensembl gene | ENSG00000147059 |
| Ensembl biotype | protein_coding |
| OMIM | 300621 |
| Entrez | 54466 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 8 protein_coding
ENST00000374906, ENST00000374908, ENST00000614076, ENST00000907357, ENST00000930838, ENST00000930839, ENST00000930840, ENST00000930841
RefSeq mRNA: 1 — MANE Select: NM_019003
NM_019003
CCDS: CCDS35312
Canonical transcript exons
ENST00000374906 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001465083 | 57137260 | 57137397 |
| ENSE00001908198 | 57135650 | 57136602 |
Expression profiles
Bgee: expression breadth ubiquitous, 159 present calls, max score 77.11.
Top tissues by expression
254 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.11 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 69.89 | gold quality |
| stromal cell of endometrium | CL:0002255 | 69.75 | gold quality |
| cortical plate | UBERON:0005343 | 68.38 | gold quality |
| apex of heart | UBERON:0002098 | 68.31 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 68.01 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 67.81 | gold quality |
| cerebellar cortex | UBERON:0002129 | 67.70 | gold quality |
| tibial nerve | UBERON:0001323 | 66.65 | gold quality |
| tendon | UBERON:0000043 | 66.21 | gold quality |
| right coronary artery | UBERON:0001625 | 65.74 | gold quality |
| cerebellum | UBERON:0002037 | 65.74 | gold quality |
| sural nerve | UBERON:0015488 | 65.61 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 65.06 | gold quality |
| ascending aorta | UBERON:0001496 | 65.05 | gold quality |
| bone marrow cell | CL:0002092 | 65.01 | silver quality |
| thoracic aorta | UBERON:0001515 | 64.93 | gold quality |
| right frontal lobe | UBERON:0002810 | 64.82 | gold quality |
| prefrontal cortex | UBERON:0000451 | 64.58 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 64.50 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 64.49 | gold quality |
| calcaneal tendon | UBERON:0003701 | 64.44 | gold quality |
| body of uterus | UBERON:0009853 | 64.31 | gold quality |
| transverse colon | UBERON:0001157 | 64.25 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 64.25 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 64.24 | gold quality |
| lower esophagus | UBERON:0013473 | 64.12 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 64.11 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 63.94 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 63.84 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.40 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
24 targeting SPIN2A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
| HSA-MIR-3680-3P | 99.75 | 72.51 | 3095 |
| HSA-MIR-4719 | 99.73 | 72.10 | 3329 |
| HSA-MIR-3618 | 99.69 | 68.57 | 1012 |
| HSA-MIR-1283 | 99.69 | 72.42 | 3009 |
| HSA-MIR-4666B | 99.64 | 68.69 | 1282 |
| HSA-MIR-587 | 99.64 | 70.86 | 2611 |
| HSA-MIR-488-3P | 99.61 | 68.79 | 1731 |
| HSA-MIR-3128 | 99.50 | 67.85 | 1258 |
| HSA-MIR-3149 | 98.77 | 67.13 | 1639 |
| HSA-MIR-455-5P | 98.74 | 67.31 | 795 |
| HSA-MIR-4709-5P | 98.51 | 67.25 | 1335 |
| HSA-MIR-934 | 98.49 | 70.44 | 581 |
| HSA-MIR-10395-3P | 98.10 | 66.70 | 1726 |
| HSA-MIR-6730-5P | 98.03 | 68.12 | 1299 |
| HSA-MIR-5681A | 97.99 | 67.17 | 1658 |
| HSA-MIR-9851-5P | 97.57 | 67.49 | 1067 |
| HSA-MIR-1227-3P | 97.36 | 66.94 | 834 |
| HSA-MIR-101-5P | 96.84 | 65.66 | 649 |
| HSA-MIR-12128 | 96.67 | 66.98 | 1471 |
Literature-anchored findings (GeneRIF, showing 1)
- SPIN-2. SPIN-2 is a novel nuclear protein from HL-60 cells that functions to regulate cell cycle progression and this activity is related to the inhibition of apoptosis following the removal of essential growth factors (PMID:12145692)
Cross-species orthologs
112 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | spinb | ENSDARG00000035697 |
| danio_rerio | spina | ENSDARG00000058949 |
| mus_musculus | Gm21719 | ENSMUSG00000079806 |
| mus_musculus | Gm21292 | ENSMUSG00000091077 |
| mus_musculus | Gm20865 | ENSMUSG00000093848 |
| mus_musculus | Gm20809 | ENSMUSG00000093868 |
| mus_musculus | Gm21454 | ENSMUSG00000093903 |
| mus_musculus | Gm20918 | ENSMUSG00000093927 |
| mus_musculus | Gm20823 | ENSMUSG00000093950 |
| mus_musculus | Gm21118 | ENSMUSG00000094052 |
| mus_musculus | Gm20826 | ENSMUSG00000094081 |
| mus_musculus | Gm20909 | ENSMUSG00000094294 |
| mus_musculus | Gm20831 | ENSMUSG00000094325 |
| mus_musculus | Gm21244 | ENSMUSG00000094484 |
| mus_musculus | Gm20821 | ENSMUSG00000094556 |
| mus_musculus | Gm20738 | ENSMUSG00000094575 |
| mus_musculus | Gm21394 | ENSMUSG00000094660 |
| mus_musculus | Gm21721 | ENSMUSG00000094679 |
| mus_musculus | Gm20747 | ENSMUSG00000094729 |
| mus_musculus | Gm20806 | ENSMUSG00000094739 |
| mus_musculus | Gm21812 | ENSMUSG00000094773 |
| mus_musculus | Gm20777 | ENSMUSG00000094813 |
| mus_musculus | Gm20828 | ENSMUSG00000094838 |
| mus_musculus | Gm21310 | ENSMUSG00000095032 |
| mus_musculus | Gm20873 | ENSMUSG00000095148 |
| mus_musculus | Gm20822 | ENSMUSG00000095172 |
| mus_musculus | Gm20834 | ENSMUSG00000095242 |
| mus_musculus | Ssty1 | ENSMUSG00000095267 |
| mus_musculus | Ssty2 | ENSMUSG00000095302 |
| mus_musculus | Gm20825 | ENSMUSG00000095324 |
| mus_musculus | Gm20795 | ENSMUSG00000095452 |
| mus_musculus | Gm20812 | ENSMUSG00000095508 |
| mus_musculus | Gm20877 | ENSMUSG00000095520 |
| mus_musculus | Gm20816 | ENSMUSG00000095634 |
| mus_musculus | Gm20854 | ENSMUSG00000095650 |
| mus_musculus | Gm20924 | ENSMUSG00000095785 |
| mus_musculus | Gm20917 | ENSMUSG00000095867 |
| mus_musculus | Gm20773 | ENSMUSG00000095900 |
| mus_musculus | Gm20737 | ENSMUSG00000095950 |
| mus_musculus | Gm21778 | ENSMUSG00000096036 |
| mus_musculus | Gm21943 | ENSMUSG00000096122 |
| mus_musculus | Gm21874 | ENSMUSG00000096223 |
| mus_musculus | Gm20914 | ENSMUSG00000096268 |
| mus_musculus | Gm20852 | ENSMUSG00000096666 |
| mus_musculus | Gm20830 | ENSMUSG00000096686 |
| mus_musculus | Gm21854 | ENSMUSG00000096706 |
| mus_musculus | Gm21425 | ENSMUSG00000096820 |
| mus_musculus | Gm20867 | ENSMUSG00000096898 |
| mus_musculus | Gm29049 | ENSMUSG00000099861 |
| mus_musculus | Gm29424 | ENSMUSG00000099948 |
| mus_musculus | Gm28171 | ENSMUSG00000100634 |
| mus_musculus | Gm20815 | ENSMUSG00000101053 |
| mus_musculus | Gm20772 | ENSMUSG00000102739 |
| mus_musculus | Gm21440 | ENSMUSG00000103468 |
| mus_musculus | Gm20807 | ENSMUSG00000104267 |
| rattus_norvegicus | LOC134486221 | ENSRNOG00000048867 |
| rattus_norvegicus | LOC134486240 | ENSRNOG00000049619 |
| rattus_norvegicus | LOC120099686 | ENSRNOG00000064259 |
| rattus_norvegicus | ENSRNOG00000065734 | |
| rattus_norvegicus | LOC134486234 | ENSRNOG00000067676 |
| rattus_norvegicus | ENSRNOG00000068289 | |
| rattus_norvegicus | LOC134484257 | ENSRNOG00000069646 |
| rattus_norvegicus | Ssty1-ps5 | ENSRNOG00000070707 |
| rattus_norvegicus | ENSRNOG00000072094 | |
| rattus_norvegicus | ENSRNOG00000072522 | |
| rattus_norvegicus | ENSRNOG00000072683 | |
| rattus_norvegicus | ENSRNOG00000072719 | |
| rattus_norvegicus | ENSRNOG00000073240 | |
| rattus_norvegicus | ENSRNOG00000073388 | |
| rattus_norvegicus | ENSRNOG00000073718 | |
| rattus_norvegicus | ENSRNOG00000074289 | |
| rattus_norvegicus | ENSRNOG00000074627 | |
| rattus_norvegicus | ENSRNOG00000075048 | |
| rattus_norvegicus | ENSRNOG00000075217 | |
| rattus_norvegicus | ENSRNOG00000075704 | |
| rattus_norvegicus | ENSRNOG00000075715 | |
| rattus_norvegicus | ENSRNOG00000076756 | |
| rattus_norvegicus | ENSRNOG00000076768 | |
| rattus_norvegicus | ENSRNOG00000077163 | |
| rattus_norvegicus | ENSRNOG00000077684 | |
| rattus_norvegicus | ENSRNOG00000077860 | |
| ENSRNOG00000078153 | ||
| rattus_norvegicus | ENSRNOG00000078247 | |
| rattus_norvegicus | ENSRNOG00000078425 | |
| rattus_norvegicus | ENSRNOG00000078859 | |
| rattus_norvegicus | ENSRNOG00000079273 | |
| rattus_norvegicus | ENSRNOG00000079973 | |
| rattus_norvegicus | ENSRNOG00000080258 | |
| rattus_norvegicus | ENSRNOG00000082759 | |
| rattus_norvegicus | ENSRNOG00000083031 | |
| rattus_norvegicus | ENSRNOG00000083094 | |
| rattus_norvegicus | ENSRNOG00000083348 | |
| rattus_norvegicus | ENSRNOG00000083477 | |
| ENSRNOG00000084216 | ||
| rattus_norvegicus | ENSRNOG00000084517 | |
| rattus_norvegicus | ENSRNOG00000084670 | |
| rattus_norvegicus | ENSRNOG00000084696 | |
| ENSRNOG00000085197 | ||
| rattus_norvegicus | ENSRNOG00000085381 | |
| rattus_norvegicus | ENSRNOG00000085696 | |
| rattus_norvegicus | ENSRNOG00000085874 | |
| rattus_norvegicus | ENSRNOG00000086556 | |
| rattus_norvegicus | ENSRNOG00000088152 | |
| rattus_norvegicus | ENSRNOG00000088255 | |
| rattus_norvegicus | ENSRNOG00000088275 | |
| rattus_norvegicus | ENSRNOG00000089025 | |
| rattus_norvegicus | ENSRNOG00000089042 | |
| rattus_norvegicus | ENSRNOG00000089633 | |
| rattus_norvegicus | ENSRNOG00000089769 | |
| rattus_norvegicus | ENSRNOG00000089859 | |
| rattus_norvegicus | ENSRNOG00000089969 | |
| rattus_norvegicus | ENSRNOG00000090248 |
Paralogs (4): SPIN1 (ENSG00000106723), SPIN4 (ENSG00000186767), SPIN2B (ENSG00000186787), SPIN3 (ENSG00000204271)
Protein
Protein identifiers
Spindlin-2A — Q99865 (reviewed: Q99865)
Alternative names: Protein DXF34, Spindlin-like protein 2A
All UniProt accessions (2): Q99865, A0A087X074
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in the regulation of cell cycle progression. Exhibits H3K4me3-binding activity.
Subunit / interactions. Interacts with C11orf84/SPINDOC.
Subcellular location. Nucleus.
Similarity. Belongs to the SPIN/STSY family.
RefSeq proteins (1): NP_061876* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003671 | SPIN/Ssty | Family |
| IPR042567 | SPIN/Ssty_sf | Homologous_superfamily |
Pfam: PF02513
UniProt features (13 total): region of interest 6, site 3, compositionally biased region 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q99865-F1 | 81.67 | 0.67 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (3): 176 (histone h3k4me3 and h3r8me2a binding); 180 (histone h3k4me3 and h3r8me2a binding); 169 (histone h3k4me3 and h3r8me2a binding)
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 50 (showing top):
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN, CAGCTG_AP4_Q5, WGTTNNNNNAAA_UNKNOWN, CHEN_METABOLIC_SYNDROM_NETWORK, DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP, chrXp11, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, DCA_UP.V1_UP, GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_DN, ZNF618_TARGET_GENES, MIR9983_3P, MIR4719, MIR1283, MIR10395_3P, MIR9851_5P
GO Biological Process (3): regulation of DNA-templated transcription (GO:0006355), gamete generation (GO:0007276), chromatin organization (GO:0006325)
GO Molecular Function (2): histone H3K4me3 reader activity (GO:0140002), protein binding (GO:0005515)
GO Cellular Component (3): nucleoplasm (GO:0005654), cytosol (GO:0005829), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| sexual reproduction | 1 |
| multicellular organismal reproductive process | 1 |
| cellular component organization | 1 |
| histone H3 reader activity | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
162 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPIN2A | IL3 | P08700 | 497 |
| SPIN2A | SPINDOC | Q9BUA3 | 446 |
| SPIN2A | LUZP6 | Q538Z0 | 433 |
| SPIN2A | PCDHGB3 | Q9Y5G1 | 394 |
| SPIN2A | TERF1 | P54274 | 387 |
| SPIN2A | RGPD5 | Q99666 | 370 |
| SPIN2A | SPNS1 | Q9H2V7 | 351 |
| SPIN2A | RPP40 | O75818 | 321 |
| SPIN2A | SPATA4 | Q8NEY3 | 311 |
| SPIN2A | PIGY | Q3MUY2 | 294 |
| SPIN2A | ACY3 | Q96HD9 | 290 |
| SPIN2A | ELMOD1 | Q8N336 | 290 |
| SPIN2A | GARIN1A | Q6NXP2 | 280 |
| SPIN2A | OR51A4 | Q8NGJ6 | 248 |
| SPIN2A | PTRH2 | Q9Y3E5 | 248 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| sseJ | AGPS | psi-mi:“MI:0914”(association) | 0.460 |
| PRDM7 | SNRPD2 | psi-mi:“MI:0914”(association) | 0.350 |
| SCRIB | CHD2 | psi-mi:“MI:0914”(association) | 0.350 |
| UBA52 | FUOM | psi-mi:“MI:0914”(association) | 0.350 |
| SIPA1L3 | SIPA1L1 | psi-mi:“MI:0914”(association) | 0.350 |
| PRKACG | HNRNPCL1 | psi-mi:“MI:0914”(association) | 0.350 |
| AFG2B | MMP24OS | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (16): SPIN2A (Affinity Capture-MS), SPIN2A (Affinity Capture-MS), SPIN2A (PCA), SPIN2A (Affinity Capture-MS), SPIN2A (Affinity Capture-MS), SPIN2A (Affinity Capture-MS), PRDM7 (Affinity Capture-MS), SPIN2A (Affinity Capture-MS), SPIN2A (Affinity Capture-MS), SPIN2A (Affinity Capture-MS), SPIN2A (Affinity Capture-MS), SPIN2A (Affinity Capture-MS), SPIN2A (Affinity Capture-MS), SPIN2A (Affinity Capture-MS), SPIN2A (Affinity Capture-MS)
ESM2 similar proteins: A2Z4C5, A7X680, B8AJL9, F4HVW5, F4I933, F4IV66, F4JR57, K4DF01, P0C7Q8, P13675, Q0WPN7, Q10PL5, Q1ECE0, Q2KI39, Q33BI9, Q4V8J7, Q56A73, Q5JUX0, Q5R997, Q5RA80, Q5RAW7, Q61142, Q6NVE3, Q6YZM6, Q8GVE5, Q8K1L2, Q8L7G0, Q8LJW3, Q8RWD9, Q8RWY4, Q8RY82, Q8W4F0, Q90WG1, Q90WG2, Q93VH2, Q93XX4, Q93YR9, Q944S3, Q94BM7, Q99865
Diamond homologs: P13675, Q2KI39, Q4V8J7, Q56A73, Q5JUX0, Q5R997, Q5RA80, Q5RAW7, Q61142, Q6NVE3, Q8K1L2, Q90WG1, Q90WG2, Q99865, Q9BPZ2, Q9Y657
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
126 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:57136954:T:A | donor_gain | 0.9000 |
| X:57136948:C:CT | donor_gain | 0.8900 |
| X:57136949:T:TT | donor_gain | 0.8900 |
| X:57136951:C:A | donor_gain | 0.7700 |
| X:57136944:CCCA:C | donor_gain | 0.7600 |
| X:57136945:CCAC:C | donor_gain | 0.7600 |
| X:57136709:AGGAG:A | donor_gain | 0.7500 |
| X:57136947:ACTAC:A | donor_gain | 0.7400 |
| X:57136948:CTACC:C | donor_gain | 0.7400 |
| X:57136767:AAGTT:A | donor_gain | 0.6900 |
| X:57136959:C:A | donor_gain | 0.6700 |
| X:57136967:G:A | donor_gain | 0.6200 |
| X:57136912:C:CA | donor_gain | 0.5800 |
| X:57136935:TG:T | donor_gain | 0.5700 |
| X:57136947:A:AC | donor_gain | 0.5600 |
| X:57136958:G:A | donor_gain | 0.5400 |
| X:57136919:C:A | donor_gain | 0.5300 |
| X:57136600:CTG:C | acceptor_gain | 0.5200 |
| X:57136598:GCCTG:G | acceptor_gain | 0.5100 |
| X:57136599:CCTGC:C | acceptor_gain | 0.5100 |
| X:57136760:C:CA | donor_gain | 0.5000 |
| X:57136368:G:C | donor_gain | 0.4900 |
| X:57136771:T:TA | donor_gain | 0.4900 |
| X:57136995:G:GA | donor_gain | 0.4900 |
| X:57136603:C:CC | acceptor_gain | 0.4800 |
| X:57136940:A:AC | donor_gain | 0.4800 |
| X:57136938:CCA:C | donor_gain | 0.4700 |
| X:57136953:C:T | donor_gain | 0.4700 |
| X:57136950:ACCCT:A | donor_gain | 0.4600 |
| X:57136951:CCCTC:C | donor_gain | 0.4600 |
AlphaMissense
1701 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:57136187:A:C | F137L | 0.997 |
| X:57136187:A:T | F137L | 0.997 |
| X:57136189:A:G | F137L | 0.997 |
| X:57135869:A:C | F243L | 0.995 |
| X:57135869:A:T | F243L | 0.995 |
| X:57135871:A:G | F243L | 0.995 |
| X:57136339:A:G | Y87H | 0.995 |
| X:57136112:A:C | F162L | 0.994 |
| X:57136112:A:T | F162L | 0.994 |
| X:57136114:A:G | F162L | 0.994 |
| X:57136383:A:T | V72D | 0.994 |
| X:57136396:A:G | W68R | 0.992 |
| X:57136396:A:T | W68R | 0.992 |
| X:57136083:A:G | L172S | 0.991 |
| X:57136188:A:C | F137C | 0.991 |
| X:57136320:A:T | V93D | 0.991 |
| X:57136193:G:C | H135Q | 0.989 |
| X:57136193:G:T | H135Q | 0.989 |
| X:57136340:T:A | K86N | 0.989 |
| X:57136340:T:G | K86N | 0.989 |
| X:57136394:C:A | W68C | 0.989 |
| X:57136394:C:G | W68C | 0.989 |
| X:57136102:A:G | Y166H | 0.988 |
| X:57136143:A:G | L152S | 0.988 |
| X:57136424:C:A | W58C | 0.988 |
| X:57136424:C:G | W58C | 0.988 |
| X:57136426:A:G | W58R | 0.988 |
| X:57136426:A:T | W58R | 0.988 |
| X:57136153:C:A | G149W | 0.987 |
| X:57136390:C:G | G70R | 0.987 |
dbSNP variants (sampled 300 via entrez): RS1001121776 (X:57142059 T>C), RS1001234172 (X:57142879 A>C), RS1001281171 (X:57142763 T>G), RS1002049027 (X:57143646 C>A), RS1002080432 (X:57143028 G>C,T), RS1002333266 (X:57143411 C>A), RS1002621421 (X:57133802 T>C), RS1002715603 (X:57139245 G>C), RS1003125649 (X:57137431 G>A), RS1003198912 (X:57138645 T>C), RS1003725464 (X:57141550 C>T), RS1003892517 (X:57138539 C>T), RS1004098161 (X:57147406 C>T), RS1004346711 (X:57138397 A>G), RS1004367511 (X:57138204 T>C)
Disease associations
OMIM: gene MIM:300621 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006661_145 | Male-pattern baldness | 6.000000e-19 |
| GCST007847_104 | Type 2 diabetes | 5.000000e-09 |
| GCST90002385_591 | High light scatter reticulocyte count | 3.000000e-32 |
| GCST90002386_502 | High light scatter reticulocyte percentage of red cells | 3.000000e-35 |
| GCST90002405_429 | Reticulocyte count | 9.000000e-30 |
| GCST90002406_580 | Reticulocyte fraction of red cells | 9.000000e-34 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007986 | reticulocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| ferrous chloride | increases expression | 1 |
| tetrachlorodian | decreases expression | 1 |
| Zoledronic Acid | increases expression, affects cotreatment | 1 |
| Fluvastatin | increases expression, affects cotreatment | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Methotrexate | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Triclosan | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Lactic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.